Algert Global LLC Adaptive Biotechnologies Corp Transaction History
Algert Global LLC
- $4.25 Billion
- Q4 2024
A detailed history of Algert Global LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Algert Global LLC holds 430,514 shares of ADPT stock, worth $3.62 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
430,514
Previous 76,323
464.07%
Holding current value
$3.62 Million
Previous $391,000
560.1%
% of portfolio
0.06%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding ADPT
# of Institutions
224Shares Held
146MCall Options Held
19.6KPut Options Held
27.2K-
Viking Global Investors LP30MShares$252 Million0.61% of portfolio
-
Rubric Capital Management LP New York, NY14.6MShares$123 Million1.45% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$90 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.42MShares$79.2 Million0.49% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.2B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...